Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508079 · ClinicalTrials.gov registry record
Evaluating the Occurence of New and Progression of Existing Peripheral Venous Disease in Leg Veins
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 1,103
- Enrollment target
NCT00508079: Completed study, sponsored by University of California, San Diego.
NCT00508079 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 1,103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508079 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 1,103 participants
- Enrollment target
Study Summary
Peripheral venous disease occurs when a vein becomes damaged or blocked. It can occur almost anywhere in the body, but is most common in the arms and legs. This study will examine people who participated in a previous venous disease study to evaluate changes in leg veins and venous disease status over a period of 11 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,103 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-01 |
What the finished NCT00508079 record still lists
NCT00508079 is an observational study that tracks outcomes without assigning an intervention. Its 1,103 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00508079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00508079 about?
NCT00508079 is a clinical study titled "Evaluating the Occurence of New and Progression of Existing Peripheral Venous Disease in Leg Veins". Peripheral venous disease occurs when a vein becomes damaged or blocked. It can occur almost anywhere in the body, but is most common in the arms and legs. This study will examine people who participated in a previous venous disease study to evaluate changes in leg veins and venous disease status ov...
What is the current status of trial NCT00508079?
This trial is currently completed. The enrollment target is 1,103 participants. The study started on 2007-07. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00508079?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia